Campus Novartis Ok
Press release

Sienna IM’s Real Estate team signs 2 new lease agreements for the Voyager campus in Rueil-Malmaison

Scroll

Sienna Investment Managers’ French Real Estate team has signed two new leases on the Voyager campus in Rueil-Malmaison. The Novartis group has signed a new 12-year lease to secure the long-term future of its French headquarters on the campus. Novartis is an international pharmaceutical company headquartered in Basel, Switzerland. Present in France across the entire drug chain, Novartis relies on scientific research and technological innovation to constantly improve the quality and accessibility of its treatments for as many people as possible.

Download PDF
Back to all news

The Voyager campus will also be home to the French headquarters of another giant in the pharmaceutical industry, a world leader in the cardiology and oncology sectors. All the employees of the French entity will move into almost 2,000 sq. m of office space in the summer of 2024. These two signings, completed directly between the parties, demonstrate the appeal of the Voyager campus. This latest-generation building offers large, rational and divisible 6,000 sq. metre office floors, a full service block (restaurant, cafeteria, fitness centre, auditorium, concierge service) set around a vast landscaped garden, and boasts a number of environmental certifications (HQE Exceptional, BREEAM Excellent, Effinergie+ RT 2012 -40%).

The Novartis Group was advised in this transaction by Upside Partners, Reedsmith and Blatter. Sienna Investment Managers was advised by Allen & Overy.

Contact us